Cigna Group — Director's Dealing 2024

Mar 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2024-03-01

Reporting Person: BRAILER DAVID J (EVP & Chief Health Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-01	Common Stock, $.01 Par Value	A	2780.0000	$0.0000	Acquired	10843.0000	Direct
2024-03-01	Common Stock, $.01 Par Value	F	412.0000	$333.3600	Disposed	10431.0000	Direct
2024-03-01	Common Stock, $.01 Par Value	F	1099.0000	$333.3600	Disposed	9332.0000	Direct

Footnotes

F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

F2: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.